We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JRSH:NASDAQJerash Holdings (US), Inc. Analysis

Data as of 2026-05-26 - not real-time

$3.41

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Jerash Holdings trades at $3.41, comfortably above its 20‑day ($3.37) and 50‑day ($3.20) moving averages, but the MACD has turned bearish and the RSI sits at 61, hinting at short‑term momentum weakening. The stock offers an eye‑catching dividend yield of 6.1% yet the payout ratio exceeds 140% and cash flow is negative, raising sustainability concerns. Valuation metrics look attractive – forward P/E is under 9, price‑to‑book is 0.68 and price‑to‑sales is 0.28, while analysts’ median target of $4.50 implies ~30% upside. High 30‑day volatility (~25%) and a beta below 1 suggest price swings are possible but not market‑wide.
Revenue grew 18% YoY to $152 M, but thin gross (16%) and operating margins (4.6%) and a net cash‑flow deficit underscore profitability pressure. Debt‑to‑equity is elevated at 15.2, though cash exceeds debt, and the company faces moderate sector and geographic exposure across the U.S., Europe and Asia. The combination of undervalued fundamentals, strong dividend appeal but cash‑flow strain, and a neutral technical backdrop frames a cautious yet potentially rewarding investment case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram
  • RSI approaching overbought territory
  • Impending ex‑dividend date likely to pressure price

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E under 9 indicating earnings upside
  • Analyst median target of $4.50 suggesting ~30% upside
  • 18% revenue growth despite modest margins

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Negative operating and free cash flow
  • High payout ratio questioning dividend sustainability
  • Cyclical consumer apparel exposure with potential recovery

Key Metrics & Analysis

Financial Health

Revenue Growth18.00%
Profit Margin1.18%
P/E Ratio24.4
ROE2.86%
ROA3.37%
Debt/Equity15.25
P/B Ratio0.7
Op. Cash Flow$-1545592
Free Cash Flow$-3115546

Technical Analysis

TrendNeutral
RSI61.1
Support$3.14
Resistance$3.59
MA 20$3.37
MA 50$3.20
MA 200$3.21
MACDBearish
VolumeIncreasing
Fear & Greed Index90.86

Valuation

Target Price$4.50
Upside/Downside31.87%
GradeUndervalued
TypeBlend
Dividend Yield6.13%

Risk Assessment

Beta0.71
Volatility25.00%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.